Home › Funds › Tribridge Partners Financial LLC › REGN

Tribridge Partners Financial LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Tribridge Partners Financial LLC reported holding 330 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$317K, representing 0.25% of its reported portfolio and ranking #44 among its reported holdings. Tribridge Partners Financial LLC has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)330 sh
Reported value held$317.22K
Portfolio Weight0.25%
First reportedQ3 2025
Last changeHold
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How Tribridge Partners Financial LLC's REGN position evolved

Tribridge Partners Financial LLC first disclosed a stake in REGN in Q3 2025 at 343 shares (US$206K). The position peaked in Q3 2026 at 330 shares, worth US$317K. Across 5 filings, Tribridge Partners Financial LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 330 shares valued at US$317K.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 343 $205.80K New
Q4 2025 343 $264.75K Hold
Q1 2026 343 $261.31K Hold
Q2 2026 330 $220.17K Reduce
Q3 2026 330 $317.22K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Nuveen, LLC (US$1.48B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Tribridge Partners Financial LLC held REGN?

Tribridge Partners Financial LLC has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Tribridge Partners Financial LLC's current position in REGN?

As of Q3 2026, Tribridge Partners Financial LLC holds 330 shares of REGN (REGENERON PHARMACEUTICALS), valued at $317.22K, representing 0.25% of its reported portfolio and ranking #44.

Has Tribridge Partners Financial LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Tribridge Partners Financial LLC held unchanged its position in REGN. The position peaked in Q3 2026 at 330 shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Nuveen, LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.